Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Regulatory Roulette: Playing In Today’s Skin-Care Market A Gamble

Executive Summary

Recent FDA warning letters to skin-care firms raise questions about the regulatory risks companies must assume to compete effectively in today’s marketplace. Former FDAer and EAS Senior Adviser John Bailey discusses the strategic decision before personal-care companies as they develop their marketing and the potential consequences of using structure/function claims.


Related Content

ASA: Olay Regenerist 'Cell By Cell' Exfoliation Claims Imply 'Physiological' Effects
FDA Warns Reviva Labs For Collagen-Building, Anti-Inflammatory Claims
Athena Appeal Decision Could Open ‘Floodgate’ For False Claims Litigation
New Litigation Risks Possible From Pending Allergan V. Athena Case
FDA Warns Former AAD President For DNA Eye Renewal Claims
Cosmetics That ‘Do Something’ A Regulatory Compliance Challenge
Will Cosmeceutical Pioneer Turn Its Wagons Around? FDA Warns Strivectin
Regulatory News In Brief: House Microbeads Bill; Oregon Eyes Children’s Cosmetics; More
Rash Of FDA Warning Letters Raises Questions For Cosmetics Industry

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts